Label: CVS MAXIMUM REDNESS RELIEF- glycerin, naphazoline hci solution/ drops

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 23, 2023

If you are a consumer or patient please visit this version.

  • Active ingredients

    Active ingredients

    Glycerin 0.5%

    Naphazoline hydrochloride 0.03%

  • PURPOSE

    Purposes

    Glycerin....Lubricant

    Naphazoline HCl....Redness Reliever

  • INDICATIONS & USAGE

    Uses

    • for the relief of redness of the eye due to minor eye irritations

    • for the temporary relief of burning and irritation due to dryness of the eye

    • for use as a protectant against further irritation or dryness of the eye

  • Warnings

    For external use only

    Do not use

    Do not use if solution changes color or becomes cloudy

    Ask a doctor before use if you have narrow angle glaucoma

    When using this product

    • to avoid contamination, do not touch tip of container to any surface

    • replace cap after using

    • overuse may produce increased redness of the eye

    • pupils may become enlarged temporarily

    Stop use and ask a doctor if

    • you experience eye pain

    • you experience changes in vision

    • you experience continued redness or irritation of the eye

    • the condition worsens or persists for more than 72 hours

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • DOSAGE & ADMINISTRATION

    Directions

    instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

  • OTHER SAFETY INFORMATION

    Other information

    • store at room temperature

    • remove contact lenses before using

  • INACTIVE INGREDIENT

    Inactive ingredients

    benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

  • PRINCIPAL DISPLAY PANEL

    box

  • INGREDIENTS AND APPEARANCE
    CVS MAXIMUM REDNESS RELIEF 
    glycerin, naphazoline hci solution/ drops
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51316-837
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE0.03 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.5 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BORIC ACID (UNII: R57ZHV85D4)  
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM BORATE (UNII: 91MBZ8H3QO)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51316-837-011 in 1 BOX03/24/2023
    115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01803/24/2023
    Labeler - CVS Pharmacy, Inc. (062312574)
    Registrant - KC Pharmaceuticals, Inc. (174450460)
    Establishment
    NameAddressID/FEIBusiness Operations
    KC Pharmaceuticals, Inc.174450460manufacture(51316-837) , pack(51316-837) , label(51316-837)